TLRY

Tilray Brands, Inc.
NasdaqGSUSDEQUITY Healthcare DELAYED
Last price
3.76
▲ 0.04 (1.07%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
3.80
Prev close
3.72
Day high
3.84
Day low
3.70
Volume
3.63M
Market cap
$558.62M
P/E (TTM)
—
52W range
3.54 – 23.20

Day trading desk

Current session · delayed
Gap from prior close
+2.15%
Prior close 3.72
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
1.97%
3.75 – 3.82
Position in range
13%
Near session low
ATR (14D)
0.15
3.93% of price
Prior day high
3.79
PDH
Prior day low
3.61
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 4.08M

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-4.30% -6.3%
1M
-16.00% -17.2%
3M
-13.50% -18.0%
6M
-41.49% -59.7%
YTD
-58.14% -72.4%
1Y
-76.67% -93.1%
3Y
-84.18% -166.4%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

11 more panels on TLRY open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
+2.81M
Net buying
Buy transactions
17
2.85M shares
Sell transactions
1
33.56K shares
Net transactions
+18
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
2.15M
Total on file
Bought 2.85MSold 33.56K

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 26, 26
GENDEL MITCHELL S
General Counsel
— 160.30K — Direct
Aug 26, 26
FALTISCHEK DENISE M
Officer
— 178.22K — Direct
Aug 26, 26
MERTON CARL A.
Chief Financial Officer
— 168.45K — Direct
Aug 26, 26
SIMON IRWIN DAVID
Chief Executive Officer
— 1.21M — Direct
Aug 6, 26
GENDEL MITCHELL S
Officer
BUY 2.50K $11.07K Direct
Aug 4, 26
MERTON CARL A.
Chief Financial Officer
BUY 10.00K $46.20K Direct
Aug 3, 26
FALTISCHEK DENISE M
Officer
BUY 2.50K $11.95K Direct
Jul 30, 26
GENDEL MITCHELL S
Officer
— 111.82K — Direct
Jul 30, 26
FALTISCHEK DENISE M
Officer
— 119.81K — Direct
Jul 30, 26
MERTON CARL A.
Chief Financial Officer
— 77.07K — Direct
Jul 30, 26
SIMON IRWIN DAVID
Chief Executive Officer
— 546.10K — Direct
Jul 29, 26
CLANACHAN DAVID F
Director
— 43.10K — Direct
Jul 29, 26
COHEN STEVEN MICHAEL
Director
— 43.10K — Direct
Jul 29, 26
HOPKINSON DAVID G.
Director
— 43.10K — Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
CLANACHAN DAVID F
Director 192.51K Conversion of Exercise of derivative security
COHEN STEVEN MICHAEL
Director 55.54K Conversion of Exercise of derivative security
FALTISCHEK DENISE M
Officer 225.05K Conversion of Exercise of derivative security
GENDEL MITCHELL S
General Counsel 200.22K Conversion of Exercise of derivative security
HERHALT JOHANN MICHAEL
Director 195.56K Conversion of Exercise of derivative security
HOPKINSON DAVID G.
Director 43.10K Conversion of Exercise of derivative security
LOONEY THOMAS PATRICK
Director 397.52K Conversion of Exercise of derivative security
MERTON CARL A.
Chief Financial Officer 215.56K Conversion of Exercise of derivative security
PERSOFSKY RENAH
Director 155.36K Conversion of Exercise of derivative security
SIMON IRWIN DAVID
Chief Executive Officer 1.31M Conversion of Exercise of derivative security

Fundamentals

TTM · reported
Market cap$558.62M
Enterprise value$660.29M
Revenue (TTM)$915.45M
Gross profit$262.59M
EBITDA$15.00M
Net income$-121.40M
EPS (TTM)$-1.10
Free cash flow$-25.03M
Total cash$231.27M
Total debt$398.40M
Book value / share$12.31
Shares outstanding147.78M
Float133.34M
Short % of float13.92%
Dividend yield0.00%
Beta (5Y)1.92

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E21.29
PEG ratio—
Price / sales—
Price / book0.31
EV / revenue0.72
EV / EBITDA44.02
Gross margin28.68%
Operating margin-0.83%
Profit margin-13.26%
Return on equity-6.82%
Return on assets-1.49%
Debt / equity24.98
Current ratio2.21
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 5 quarters
Blank means not reported, not zero
Line item2026202520242023YoY
Total revenue $915.45M$821.31M$788.94M$627.12M +11.5%
Operating revenue $915.45M$821.31M$788.94M$627.12M +11.5%
Cost of revenue $655.01M$580.74M$565.59M$480.16M +12.8%
Gross profit $260.44M$240.57M$223.35M$146.96M +8.3%
Research & development $361.00K$284.00K$635.00K$682.00K +27.1%
Selling, general & admin $295.76M$259.48M$250.72M$230.98M +14.0%
Total operating expense $315.70M$348.38M$336.11M$325.15M -9.4%
Operating income -$55.26M-$107.81M-$112.76M-$178.19M +48.7%
Net interest income -$23.66M-$29.95M-$36.43M-$13.59M +21.0%
Pre-tax income -$88.06M-$2.30B-$249.02M-$1.45B +96.2%
Tax provision $17.10M-$121.02M-$26.62M-$7.18M +114.1%
Net income -$121.40M-$2.19B-$244.98M-$1.45B +94.4%
Net income to common -$121.40M-$2.19B-$244.98M-$1.45B +94.4%
Basic EPS -1.09-24.60-3.30-23.50 +95.6%
Diluted EPS -1.09-24.60-3.30-23.50 +95.6%
EBIT -$58.15M-$2.26B-$199.76M-$1.40B +97.4%
EBITDA $9.45M-$2.13B-$72.84M-$1.27B +100.4%
Basic shares 111.83M89.03M67.40M61.40M +25.6%
Diluted shares 111.83M89.03M67.40M61.40M +25.6%

Options analytics

Account required
Put / call volume
1.31
Put-heavy session
Put / call open interest
0.76
Positioning, not flow
Max pain
4.00
+5.8% from spot
ATM implied vol
25.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
1.25K
Contracts, this expiry
Put volume
1.63K
Contracts, this expiry
Heaviest call OI
4.00
3.53K contracts
Heaviest put OI
3.50
4.08K contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
May 2026 0.210.05 -76.2%
Feb 2026 0.070.02 -71.4%
Nov 2025 0.00-0.02 0.0%
Aug 2025 0.000.00 0.0%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.14 2 $266.80M +27.4%
Next quarter 0.03 1 $270.62M +24.4%
Current year 0.06 2 $1.11B +21.7%
Next year 0.18 2 $1.17B +4.8%

Analyst targets & ownership

Account required
Mean target$7.16
High target$17.00
Low target$4.00
Implied upside90.33%
Analyst count8
ConsensusBUY
Strong buy / Buy0 / 3
Hold3
Sell / Strong sell0 / 0
Held by insiders1.59%
Held by institutions10.08%
Institutions holding279
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
3.87
-2.87% from price
SMA 20
3.97
-4.76% from price
SMA 50
4.31
-12.39% from price
SMA 100
4.55
-17.43% from price
SMA 200
6.08
-37.79% from price
EMA 12
3.87
-2.76% from price
EMA 26
4.05
-7.06% from price
EMA 50
4.25
-11.62% from price
RSI (14)
39.2
Neutral
MACD (12,26,9)
-0.18
Hist -0.02
ATR (14)
0.15
3.91% of price
Realised vol 30D
40.2%
Annualised
Bollinger upper
4.34
20, 2σ
Bollinger lower
3.60
20, 2σ
50 / 200 cross
Death
4.31 vs 6.08
Trend bias
Below 200
-37.79%

Options chain

Account required
Expiry
Spot 3.76
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
1.66
More volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
40.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-83.0%
Peak to trough
Max drawdown 5Y
-97.3%
Peak to trough
ATR 14
0.15
3.91% of price
Beta (reported)
1.92
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
19.42M
Prior 18.43M
Change vs prior
+5.4%
Shorts adding
% of float
13.92%
Elevated
% of shares out
13.83%
Against total outstanding
Days to cover
5.3
Crowded exit
Float
133.34M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

78 on file
DateFirm ActionFromTo
Jul 14, 26 TD Cowen MAINTAINED Buy Buy
Apr 2, 26 Roth Capital UPGRADE Neutral Buy
Mar 30, 26 TD Cowen MAINTAINED Buy Buy
Jan 20, 26 Roth Capital MAINTAINED Neutral Neutral
Aug 25, 25 Jefferies MAINTAINED Buy Buy
Jul 29, 25 Zelman & Assoc MAINTAINED Neutral Neutral
Apr 9, 25 Piper Sandler MAINTAINED Neutral Neutral
Oct 11, 24 Roth MKM MAINTAINED Neutral Neutral
Jun 27, 24 Zuanic & Associates INITIATED — Neutral
Apr 10, 24 CIBC MAINTAINED Neutral Neutral
Sep 1, 23 Roth MKM MAINTAINED Neutral Neutral
Apr 11, 23 TD Cowen MAINTAINED — Outperform

Dividends & splits

Declared · from the issuer
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:10
Split dateDec 2, 2025

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.